Time Perception Altered by Exercise: Exploring the Secrets of the Mind

A groundbreaking study published in Brain and Behavior has shed new light on the intricate relationship between physical exercise and our perception of time. This research reveals that engaging in exercise can actually make time appear to move slower, a fascinating aspect of human psychology that has significant implications for athletes and fitness enthusiasts alike.

The concept of psychological time differing from chronological time was beautifully illustrated by Albert Einstein’s analogy about sitting with a pretty girl versus sitting on a hot stove. Previous studies have already demonstrated that physical exercise can distort our sense of time, making it seem like it moves more slowly. However, these studies were limited to fixed-intensity exercise and failed to account for self-paced, variable-intensity efforts seen in competitive sports.

This led to the current study conducted by renowned psychologist Andrew Mark Edwards from Canterbury Christ Church University. The study aimed to investigate how time perception is affected during exercis

Yogurt, a food that has been part of the human diet for millennia, has earned its place as a healthy and versatile component of the modern diet.

Originally from Western Asia and the Middle East, its name comes from the Turkish “yo?urmak”, which means to curdle or thicken, referring to the fermentation process that transforms milk into yogurt.

According to experts at Harvard University’s TH Chan School of Public Health, yogurt is produced when heated milk is combined with bacteria, such as Lactobacillus bulgaricus and Streptococcus thermo

Eating fruits and vegetables helps maintain good cardiovascular health. But not all vegetables are equal, as Chinese researchers show in the scientific journal Food & Function. According to them, a family of vegetables is particularly protective for the heart and arteries, much more than other vegetables. One of these vegetables, little consumed in France, would be particularly good for reducing cholesterol, one of the main cardiovascular risk factors.

This vegetable is easily found in supermarkets, in greengrocers, in markets or even in Asian grocery stores

Lipitor, Lipitor Plus

[팜뉴스=김민건 기자] In 1985, Dr. Bruce Roth of Warner-Lambert (now Pfizer) succeeded in synthesizing the calcium atorvastatin for the first time. Subsequently, a joint sales agreement with Pfizer was reached in 1996. The brand name of this product became “Lipitor”.

Lipitor was released in Korea in 1999 under the name Zarato. In June 2000, Pfizer and Warner-Lambert decided to merge, building a reputation as a blockbuster drug that led the global dyslipidemia market for 25 years.

In Korea, it is prescribed to 1 million people annually and ranked first in the number of single and combined statin prescriptions for 20 years from 2003 to 2023 (based on IQVIA data). The name Lipitor itself has become a trademark.

Although its patent expired in 2009, it has maintained its number 1 position on the market for over 20 years. How can we get overwhelming prescriptions in the highly competitive dyslipidemia prescription market?

Lipitor’s survival strategy is based on consistent clinical research data. The secret to the growth has been a series of efforts, such as demonstrating the benefits for patients with high blood pressure and diabetes, as well as those who have suffered heart attacks, and improving convenience by expanding the range.

On the 24th, Lipitor plays an important role in the treatment of hyperlipidemia in Korea and around the world and is prescribed to save the lives of patients with dyslipidemia.

The most representative clinical study of Lipitor is the ASCOT-LLA study. This clinical trial is a large-scale study that randomly assigned 10,305 patients aged 40 to 79 years with three or more cardiovascular diseases, including hypertension.

As a result of the follow-up of the Lipitor 10 mg group and the placebo group for 3-5 years, the risk of cardiovascular events in the Lipitor 10 mg group (5,168 people) was reduced by 36% compared to the placebo group (5,137 people). .

The next representative clinical study is the “CARDS” study. This study randomly assigned 2,838 patients with type 2 diabetes between the ages of 40 and 75 years to receive Lipitor 10 mg (1,428 patients) or a placebo group (1,410 patients) and observed them for more than 3 years. had major cardiovascular events. The risk was reduced by 37%. The main reason for this study is that diabetic patients have

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertisin

A groundbreaking study conducted by researchers at Ohio State University has uncovered a significant link between spinal cord injuries (SCI) and metabolic dysfunctions, such as diabetes and heart disease. The study reveals that abnormal neuronal activities following an SCI lead to excessive breakdown of triglycerides in fat tissue, releasing harmful compounds into organs like the liver.

However, the research team has now identified a potential solution. In animal models, the administration of gabapentin, a nerve pain medication, proved effective in preventing these metabolic effects, paving the way for potential new treatments to mitigate the secondary health issues caused by spinal injuries.

Key Findings

Source: Ohio State University

A new animal study conducted at Ohio State University has revealed a strong correlation between abnormal post-injury neuronal activity and the development of pathological conditions such as diabetes, hea

Potential Future Trends in Weight-Loss Drugs: An Extensive Analysis

When it comes to weight-loss drugs, the world has witnessed a remarkable breakthrough that has the potential to revolutionize the industry. Financial analyst Emily Field, who was commissioned by Barclays, predicts that these new generation weight-loss drugs could have implications comparable to the invention of the smartphone.

For the past 40 years, the world has been grappling with an alarming increase in obesity rates, with numbers tripling since 1975. However, thanks to these groundbreaking drugs, the trend might finally be on the verge of a dramatic reversal. Unlike their predecessors, these new medications work in a completely different way, resulting in astonishing physical shrinking.

Ozempic and Wegovy, two such drugs, have already shown incredible results, with individuals losing an average of 15 percent of their body weight within a year. But the true spectacle lies in the newer drugs that are currently in development, promising an unprecedented weight loss of up to 24 percent. The impact on individuals’ overall health and well-being cannot be underestimated.

Implications and Connections to Current Events

The implications of these findings are profound and wide-ranging. In a world where obesity has become a growing concern, the potentia